Some Farmers Still Don’t Trust CRISPR, Thanks to GMOs – Motherboard
Motherboard |
Some Farmers Still Don’t Trust CRISPR, Thanks to GMOs
Motherboard One way CRISPR could help is by speeding up the breeding process. Unlike GMOs, where a foreign gene is inserted into the crop to create a change, with CRISPR, researchers can make small changes in the native DNA that could also occur there in nature … |
Dispatch Tribunal |
Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) Stock
The Ledger Gazette Crispr Therapeutics logo Crispr Therapeutics AG (NASDAQ:CRSP) insider Tyler Dylan-Hyde sold 15,000 shares of Crispr Therapeutics stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $18.90, for a … Crispr Therapeutics’ (CRSP) Hold Rating Reiterated at CannThe Lincolnian Online Crispr Therapeutics (NASDAQ:CRSP) Research Coverage Started at OppenheimerStockNewsTimes A Look at 2 Trending Stocks: CRISPR Therapeutics AG (CRSP), Athersys, Inc. (ATHX)Post Analyst Dispatch Tribunal all 14 news articles » |
Dispatch Tribunal |
Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) Stock
The Ledger Gazette Crispr Therapeutics logo Crispr Therapeutics AG (NASDAQ:CRSP) insider Tyler Dylan-Hyde sold 15,000 shares of Crispr Therapeutics stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $18.90, for a … Crispr Therapeutics’ (CRSP) Hold Rating Reiterated at CannThe Lincolnian Online Crispr Therapeutics (NASDAQ:CRSP) Research Coverage Started at OppenheimerStockNewsTimes A Look at 2 Trending Stocks: CRISPR Therapeutics AG (CRSP), Athersys, Inc. (ATHX)Post Analyst Dispatch Tribunal all 14 news articles » |
The Ledger Gazette |
CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board
GlobeNewswire (press release) “It has been a privilege to be part of CRISPR’s growth over the past two years, as the company has made great strides to translate the CRISPR/Cas9 platform into transformative therapies. With the recent filing of a clinical trial application for β … Crispr Therapeutics (CRSP) Rating Reiterated by OppenheimerThe Lincolnian Online Crispr Therapeutics (NASDAQ:CRSP) Research Coverage Started at OppenheimerStockNewsTimes A Look at 2 Trending Stocks: CRISPR Therapeutics AG (CRSP), Athersys, Inc. (ATHX)Post Analyst Analyst Journal –Week Herald –MoneyMakingArticles all 12 news articles » |